Merck wins European approval for first-ever Ebola vaccine
FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermid (Reuters) – U.S. drugmaker…
Juul Labs to stop sales of mint-flavored nicotine pods in U.S
(Reuters) – E-cigarette maker Juul Labs Inc will immediately stop selling its mint-flavored nicotine cartridges in the United States, the company said on Thursday, after new signs that the mint…
Britain’s AstraZeneca to distribute Sun Pharma cancer drugs in China
FILE PHOTO: A sign is seen at an AstraZeneca site in Macclesfield, central England May 19, 2014. REUTERS/Phil Noble BENGALURU (Reuters) – Top Indian drugmaker Sun Pharmaceutical Industries Ltd said…
Novartis arthritis drug fails to prove it is significantly better than rival
FILE PHOTO: Swiss drugmaker Novartis’ logo is seen at the company’s plant in the northern Swiss town of Stein, Switzerland October 23, 2017. REUTERS/Arnd Wiegmann/File Photo ZURICH (Reuters) – A…
Amgen posts higher biosimilar sales, ends neuroscience program
(Reuters) – Amgen Inc on Tuesday said competition for its older drugs sent third-quarter revenue down 3%, but biosimilar sales were strong and the quarterly results were ahead of Wall…
J&J says new tests find no asbestos in same baby powder bottle that sparked recall
(Reuters) – Johnson & Johnson (JNJ.N) said on Tuesday that 15 new tests found no asbestos in a bottle of baby powder that the U.S. Food and Drug Administration says…
J&J says new tests find no asbestos in same baby powder bottle that sparked recall
(Reuters) – Johnson & Johnson (JNJ.N) said on Tuesday that 15 new tests found no asbestos in a bottle of baby powder that the U.S. Food and Drug Administration says…
Ex-FDA chief Gottlieb sees investment opportunity in ‘unloved’ antibiotics
NEW YORK (Reuters) – As a private investor, former U.S. Food and Drug Administration Commissioner Scott Gottlieb is focused on an area where few have found success in recent years:…
Johnson & Johnson CEO testified Baby Powder was safe 13 days before FDA bombshell
LOS ANGELES/NEW YORK (Reuters) – Facing off against a plaintiff’s lawyer for the first time about Johnson & Johnson’s Baby Powder, the company’s Chief Executive Alex Gorsky earlier this month…
Two charities to pay $6 million to resolve U.S. pharma kickback probe
BOSTON (Reuters) – Two charities will pay $6 million to resolve claims they operated as pass-throughs for seven pharmaceutical companies to pay kickbacks to Medicare patients using their high-priced medications,…